폐암의 방사선치료 결과
Result of Radiation Therapy for the Lung Cancer

대한치료방사선과학회지 1989년 7권 2호 p.213 ~ p.225

김주영(Kim Joo-Young) - 고려대학교 의과대학 치료방사선과
최명선(Choi Myung-Sun) - 고려대학교 의과대학 치료방사선과
서원혁(Suh Won-Hyuck) - 고려대학교 의과대학 치료방사선과

Abstract

An analysis has been made of two hundred seven patients who were treated at the department of Radiation Oncology of Korea University Hospital for lung cancer from January 1981 through December 1986. There were 137 patients of nonsmall cell carcinoma (137/207, 66%), 26 patients of small cell carcinoma (26/207, 12.5%) and 44 patients of unproven histology, By aims of treatment, there were 104 patients (104/207, 50%) treated for cure, 89 patients (89/207, 42.9%) for palliation and 14 patients teated postoperatively. In 22 out of 207 patients, chemotherapy was done with radiotherapy, 12 of which were patients with small cell carcinoma. Stage II patients were 49(49/207, 23.6%), stage III patients were 157(157/207, 75.8%) and one patient had an occult cancer. The tumor was initially measured by CAT scan and chest X-rays in the 165 (165/207, 79.7%)patients, among which 117 patients had tumor diameter more than 5cm and 48 patients less than 5cm. Radiation therapy was given with Cobalt 60 teletherapy unit and the treatment volume encompassed primary tumor and the mediastinum. For curative aim, daily tumor dose of 180 cGy was given up to the range of 5,400~6,120 cGy/30~34 F/6~7 week period and for palliative aim, daily tumor dose of 300 cGy was given up to the range of 3,600 ~ 4,500 cGy/12~15 F/2~3 week period.

키워드

Lung Cancer, Radiotherapy
원문 및 링크아웃 정보
등재저널 정보
주제코드
주제명(Target field)
연구대상(Population)
연구참여(Sample size)
대상성별(Gender)
질병특성(Condition Category)
연구환경(Setting)
연구설계(Study Design)
연구기간(Period)
중재방법(Intervention Type)
중재명칭(Intervention Name)
키워드(Keyword)
유효성결과(Recomendation)
For curative aim, daily tumor dose of 180 cGy was given up to the range of 5,400~6,120 cGy/30~34 F/6~7 week period and for palliative aim, daily tumor dose of 300 cGy was given up to the range of 3,600 ~ 4,500 cGy/12~15 F/2~3 week period.
연구비지원(Fund Source)
근거수준평가(Evidence Hierarchy)
출판년도(Year)
참여저자수(Authors)
대표저자
DOI
KCD코드
ICD 03
건강보험코드